A new study suggests routine gastrointestinal (GI) endoscopy is not needed for most patients with mucinous ovarian cancer in the perioperative setting due to a lack of statistically significant ...

Mucinous ovarian carcinoma (MOC) is a rare histotype that responds poorly to chemotherapy. MOC often exhibits genetic events that may be susceptible to existing or novel targeted therapies. Genetic ...

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer. Scientists at the Keck School of Medicine, University of Southern California, have ...

The largest study to date of mucinous ovarian cancer (MOC) offers hope for a more personalized treatment approach in patients diagnosed early with this rare form of the disease. MOC accounts for only ...

Phase II study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-FU, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in ...

Prognostic value of Gli1 expression and its association with hormone receptors in localized breast cancer. Molecular pathology from lipid profiles of human transitional cell carcinoma of the urinary ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...